4//SEC Filing
CytomX Therapeutics, Inc. 4
Accession 0000899243-17-018238
$CTMXCIK 0001501989operating
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 8:07 PM ET
Size
15.9 KB
Accession
0000899243-17-018238
Insider Transaction Report
Form 4
THIRD ROCK VENTURES LP
10% Owner
Transactions
- Other
Common Stock
2017-07-13−850,000→ 4,320,348 total
Holdings
- 89,292
Common Stock
- 60,934
Common Stock
- 74,293
Common Stock
Third Rock Ventures GP, L.P.
10% Owner
Transactions
- Other
Common Stock
2017-07-13−850,000→ 4,320,348 total
Holdings
- 74,293
Common Stock
- 60,934
Common Stock
- 89,292
Common Stock
LEVIN MARK J
10% Owner
Transactions
- Other
Common Stock
2017-07-13−850,000→ 4,320,348 total
Holdings
- 60,934
Common Stock
- 89,292
Common Stock
- 74,293
Common Stock
TRV GP, LLC
10% Owner
Transactions
- Other
Common Stock
2017-07-13−850,000→ 4,320,348 total
Holdings
- 60,934
Common Stock
- 74,293
Common Stock
- 89,292
Common Stock
TEPPER ROBERT I
10% Owner
Transactions
- Other
Common Stock
2017-07-13−850,000→ 4,320,348 total
Holdings
- 89,292
Common Stock
- 60,934
Common Stock
- 74,293
Common Stock
STARR KEVIN P
10% Owner
Transactions
- Other
Common Stock
2017-07-13−850,000→ 4,320,348 total
Holdings
- 74,293
Common Stock
- 89,292
Common Stock
- 60,934
Common Stock
Footnotes (5)
- [F1]Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. ("TRV"), TRV distributed on July 13, 2017, for no consideration, 850,000 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Third Rock Ventures GP, L.P. ("TRV GP"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.
- [F2]These shares are directly held by TRV. The general partner of TRV is TRV GP. The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- [F3]These shares are directly held by Starr. Includes Shares received in the distributions described in footnote (1) above.
- [F4]These shares are directly held by Levin. Includes Shares received in the distributions described in footnote (1) above.
- [F5]These shares are directly held by Tepper. Includes Shares received in the distributions described in footnote (1) above.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001501989
Filing Metadata
- Form type
- 4
- Filed
- Jul 12, 8:00 PM ET
- Accepted
- Jul 13, 8:07 PM ET
- Size
- 15.9 KB